Our Team
SOMAÍ has brought together an all-star team of scientists and key opinion leaders worldwide with various clinical experiences to guide SOMAÍ's product development and acceptance globally. SOMAÍ stresses education and continual R&D, which started in the USA as transformative developments, to help EU doctors and patients properly diagnose and treat individual indications by providing variable dosage choices.
Michael Sassano
Founder & Interim CEO
Ralph Steffen
Industrial Director
Rita Barata
Chief Marketing Officer
Anton Nakhodkin
Managing Director
Logan Marynissen
Research and Development Director
Dr. Iva Vinhas
Quality Control Director
Renato Cunha
Technical and Quality Director
Vasiliki Koutelieri
Country Director, Portugal
Mafalda Morgado
Regulatory Affairs
George Bellow
Co-Founder, Emerging Markets
Dr. António Marques da Costa
Scientific Advisor
